bpc-157 genotoxicity ames test Substance depletion of volatile monoterpenes – A confounding factor for toxicity testing in the fluctuation Genetic Toxicology Testing - Scantox

Pharmacology Biochemistry and Behavior, 135 , 199-209

BPC-157, a stable gastric pentadecapeptide, demonstrates broader systemic healing effects across multiple tissue types including tendons, muscles, and the gastrointestinal tract through angiogenic and growth factor pathways

But if people ask me, Would you take it? I would say no, citing worries about the long-term effects on things like tumor growth and whether it can enhance already proven levers like good nutrition, sleep, and rehab

It has been shown to improve cognitive function by enhancing memory and learning in people

Earlier-stage research and a narrower use case

Headline results announced in December 2024 and presented in full at the American Diabetes Associations 85th Scientific Sessions in June 2025, with simultaneous publication in the New England Journal of Medicine, showed that CagriSema produced a mean weight reduction of 22.7% at 68 weeks, significantly outperforming placebo